Influenza and autoimmunity

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 619-626

  Toplak, Nataša ^a   Avčin, Tadej ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

Author keywords

Autoantibodies; Autoimmunity; Influenza; Influenza vaccination

Indexed keywords

ALPHA INTERFERON; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LUPUS ANTICOAGULANT; MALATHION; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID ANTIBODY; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TRIPLE VACCINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANAPHYLACTOID PURPURA; ANTIGEN PRESENTING CELL; ANTIPHOSPHOLIPID SYNDROME; ATHEROSCLEROSIS; AUTISM; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CONFERENCE PAPER; DISEASE ASSOCIATION; FEVER; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VACCINATION; INSULIN DEPENDENT DIABETES MELLITUS; LOWER RESPIRATORY TRACT INFECTION; MALAISE; MICROSCOPIC POLYANGIITIS; MULTIPLE SCLEROSIS; MYALGIA; MYCOPLASMA PNEUMONIAE; MYOCARDITIS; OTITIS MEDIA; PATHOGENESIS; RASMUSSEN SYNDROME; RHEUMATOID ARTHRITIS; RISK FACTOR; SCHIZOPHRENIA; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; UPPER RESPIRATORY TRACT INFECTION; VACCINATION REACTION; VASCULITIS;

EID: 69949158137     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04759.x     Document Type: Conference Paper

References (30)

1. CDC. MMWR. 2008. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP) 57: 1-60.
2. Molina, V. & Y. Shoenfeld. 2005. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 38: 235-245.
3. Toplak, N., T. Kveder, A. Trampu?s-Bakija, et al. 2008. Autoimmune response following annual influenza vaccination in 92 apparently healthy adults. Autoimmun. Rev. 8: 134-138.
4. Heer, A.K., A. Shamshiev, A. Donda, et al. 2007. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J. Immunol. 178: 2182-2191.
5. Pisetsky, D.S. 2008. The role of innate immunity in the induction of autoimmunity. Autoimmun. Rev. 8: 69-72.
6. Marks, D.J.B., N.A. Mitchison, A.W. Segal, et al. 2006. Can unresolved infection precipitate autoimmune disease? Curr. Top. Microbiol. Immunol. 305: 105-125.
7. Doria, A., M. Canova, M. Tonon, et al. 2008. Infections as triggers and complications of systemic lupus erythematosus. Autoimmun. Rev. 8: 24-28.
8. Woods, A., F. Monneaux, P. Soulas-Sprauel, et al. 2007. Influenza virus induced type I interferon leads to polyclonal B-cell activation but does not break down B-cell tolerance. J. V i r o l . 81: 12525-12534.
9. Avcin, T. & N. Toplak. 2007. Antiphospholipid antibodies in response to infection. Curr. Rheumatol. Rep. 9: 212-8.
10. Blank, M., I. Krause, M. Fridkin, et al. 2002. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J. Clin. Invest. 109: 797-804.
11. Fruntes, V. & F. Limosin. 2008. Schizophrenia and viral infection during neurodevelopment: A pathogenesis model? Med. Sci. Monit. 14: RA71-RA77.
12. Brown, A.S., M.D. Begg, S. Gravenstein, et al. 2004. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 61: 774-780.
13. Libbey, J.E., T.L. Sweeten, W.M. McMachon, et al. 2005. Autistic disorder and viral infections. J. Neurovi-rol. 11: 1-10.
14. Kazmierski, R., M. Wender, P. Guzik, et al. 2004. Association of influenza incidence with multiple sclerosis on set. Folia. Neuropathol. 42: 19-23.
15. Krone, B., D. Pohl, K. Rostasy, et al. 2008. Common infectious agents in multiple sclerosis: a case control study in children. Mult. Scler. 14: 136-139.
16. Tam, C.C., S.J. O'Brien, I. Petrsen, et al. 2007. Guillain-Barre syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research data base. PLoS ONE 2: e344.
17. Takahashi, Y., K. Matsuda, Y. Kubota, et al. 2006. Vaccination and infection as causative factors in Japanese patients with Rasmussen syndrome: Molecular mimicry and HLA class I. Clin. Dev. Immunol. 13: 381-387.
18. Goldacre, M.J., C.J. Wotton, D. Yeates, et al. 2005. Hospital admission for selected single virus infection prior to diabetes mellitus. Diabetes Res. Clin. Pract. 69: 256-261.
19. Sano, H., J. Terasaki, C. Tsutsumi, et al. 2008. A case of fulminant type 1 diabetes mellitus after influenza B infection. Diabetes Res. Clin. Pract. 79: 8-9.
20. Gurevich, V.S., V.M. Pleskov & M.V. Levaya. 2005. Autoimmune nature of influenza atherogenicity. Ann. N. Y. Acad. Sci. 1050: 410-416.
21. Niederhoff, H., W. Pernice, H.H. Sedlacek, et al. 1979. Henoch-Schonlein purpura. Dtsch. Med. Wo c h e n s c h r. 104: 1567-1571.
22. Haber, P., F. DeStefano, F.J. Angulo, et al. 2004. Guillain-Barre syndrome following influenza vaccination. JAMA 24: 2478-2481.
23. Lasky, T., G.J. Terracciano, L. Magder, et al. 1998. The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N. Engl. J. Med. 339: 1797-1802.
24. Juurlink, D.N., T.A. Stukel & J. Kwong. 2006. Guillain-Barre syndrome after influenza vaccination in adults: a population based study. Arch. Intern. Med. 166: 2217-2221.
25. Mormile, R., V.D. Alterio, G. Treccagnoli, et al. 2004. Henoch-Schonlein purpura with antiphospho-lipid antibodies after influenza vaccination: how fearful is it in children? Vaccine 23: 567-568.
26. Uji, M., H. Matsushita & S. Iwata. 2005. Microscopic polyangiitis after influenza vaccination. Intern. Med. 44: 892-896.
27. Iyngkaran, P., V. Limaye, C. Hill, et al. 2003. Rheumatoid vasculitis following influenza vaccination. Rheumatology 7: 907-909.
28. Tarjan, P., S. Sipka, G. Lakos, et al. 2006. Influenza vaccination and the production of anti-phospholipid antibodies in patients with systemic lupus erythematosus. Scand. J. Rheumatol. 35: 241-249.
29. Abu-Shakra, M., J. Press, D. Buskila, et al. 2007. Influenza vaccination of patients with systemic lupus erythematosus: safety and immunogenecity issues. Autoimmun. Rev. 6: 543-546.
30. Conti, F., S. Rezai & G. Valesini. 2008. Vaccination and autoimmune rheumatic diseases. Autoimmun. Rev. 8: 124-128.